Mount Sinai researchers explore new depression treatment targeting brain’s potassium channels
New Hope for Depression Treatment: Targeting Brain Cell Activity For millions battling major depressive disorder, current treatments offer limited relief. But groundbreaking research from the Icahn School of Medicine at Mount Sinai suggests a fundamentally new approach: targeting potassium channels within the brain to modulate brain cell activity. Unlocking the Brain’s Potential: KCNQ Channels and … Read more